Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma - Poll - MDSpire

Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma

  • By

  • Guofu Lin

  • Lanlan Lin

  • Jianming Zhao

  • Gongping Chen

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma

  • by Guofu Lin, Lanlan Lin, Jianming Zhao, Gongping Chen

  • May 25, 2026

Related Content

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer